BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 3, 2026
Home » Authors » Lynn Yoffee

Lynn Yoffee

lynn.yoffee@clarivate.com
Articles

ARTICLES

FDA clears biospace med's 3-D/standing X-ray system

Oct. 10, 2008
By Lynn Yoffee
Surgeons now have a much more realistic image to use when planning spine and knee procedures with the FDA's 510(k) clearance this week of biospace med's (Paris/Marietta, Georgia) X-ray imaging system, the first that allows patients to stand up during the process and produces 3-D images. (Medical Device Daily)
Read More

DiagNano's quantum dots offer more accurate disease detection

Oct. 9, 2008
By Lynn Yoffee
ATLANTA — While Georgia Institute of Technology (Georgia Tech; Atlanta) student Brad Kairdolf was studying biomedical engineering, his wife Alyssa was diagnosed with thyroid cancer. Because the first pathology report was negative, she ended up having to go back into surgery a week after the initial biopsy when further analysis of the tissue sample confirmed cancer. (Diagnostics & Imaging Week)
Read More

DiagNano's quantum dots offer more accurate disease detection

Oct. 3, 2008
By Lynn Yoffee

Cepheid's GeneXpert rapid MRSA test wins FDA approval

Oct. 2, 2008
By Lynn Yoffee
There is light at the end of the infection control tunnel – particularly when it comes to the growing incidences of methicillin-resistant Staphylococcus aureus (MRSA) infections – with the FDA's clearance this week of Cepheid's (Sunnyvale, California) GeneXpert MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which can provide clinicians with results in less than a hour, compared to traditional cultured tests which can take days. (Diagnostics & Imaging Week)
Read More

SwiftMD starts as first 24/7 emergency physician access

Oct. 2, 2008
By Lynn Yoffee

CartiMesh may be next best knee repair on the horizon

Oct. 2, 2008
By Lynn Yoffee

Cepheid's GeneXpert rapid MRSA test wins FDA approval

Oct. 1, 2008
By Lynn Yoffee
There is light at the end of the infection control tunnel – particularly when it comes to the growing incidences of methicillin-resistant Staphylococcus aureus (MRSA) infections – with the FDA's clearance this week of Cepheid's (Sunnyvale, California) GeneXpert MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which can provide clinicians with results in less than a hour, compared to traditional cultured tests which can take days. (Medical Device Daily)
Read More

SwiftMD starts as first 24/7 emergency physician access

Sep. 29, 2008
By Lynn Yoffee

Steady growth of med tech in Georgia's 'Innovation Crescent'

Sep. 26, 2008
By Lynn Yoffee
ATLANTA – Georgia may not be an official biotech or med-tech hotbed, but it's moving in that direction as demonstrated by the breadth of companies and researchers featured during this week's Georgia Life Sciences Summit 2008. And, despite venture capital funding difficulties in recent times, the state has seen steady growth with 300 life sciences companies calling the southern state home that now boasts nearly $8 billion in annual sales of 400 life science products. (Medical Device Daily)
Read More

Prosthetic vein valve developed at Ga Tech may offer solution for CVI

Sep. 23, 2008
By Lynn Yoffee
View All Articles by Lynn Yoffee

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing